NextGen Omics, Spatial & Data US 2027
Sheraton Boston Hotel, MA
NextGen Omics, Spatial & Data US 2026
Thank You For Attending
Together, we can accelerate life changing, targeted, treatments.
The event featured engaging content and discussions across the entire multi-omics portfolio, underscoring our collective commitment to advancing multi-omics R&D.

Day One Highlights

Decoding Immunotherapy
Arutha Kulasinghe opened the event to explore how spatial omics & high-plex profiling are transforming analysis of the tumour microenvironment.
.png)
Genomics, But Not as You Know It
Jackson Brougher shared how genomics is being used to better understand & reduce risk in human spaceflight, with insights from the EXPAND program.
.png)
Multi-Omics After Hours
Heatmap Happy Hour brought everyone together to unwind, swap ideas, & keep the multi-omics conversations going, with plenty of cocktails had throughout the evening.
Day Two Highlights

Inclusive Leadership in Practice
This breakfast session brought delegates together to explore inclusive leadership, with insights from Aridaman Pandit on turning intent into tangible impact.
.png?width=1000&height=1000&name=ngb%20onsite%20(5).png)
When Spatial Data Comes Together
The GESTALT workshop highlights the value of connected datasets and collaborative thinking in driving more meaningful insights from spatial biology.
.png?width=1080&height=1080&name=ngb%20onsite%20(2).png)
Making Multi-Omics Work in the Clinic
Led by Sunwha Kim, this discussion focuses on predicting response, integrating complex datasets, and what still needs to be solved.
Advancing Therapeutic Innovation Through Multi-Omics Research
NextGen Omics & Spatial Biology connects thought leaders, researchers, and experts with pharmaceutical & biotech representatives to discuss the latest innovations across the fields of multi-omics.
There are three dedicated programmes running across two full days, which together will explore multi-omics from technological development to therapeutic applications and analysis, making this a must-attend event for anyone working in clinical diagnostics, single cell & spatial biology.
Hear from past attendees of last year's Biologics 2024 conference
Explore the NextGen Omics & Spatial Biology US 2025 Programme

NextGen Biomed 2025 is supported by our
Scientific Programme Partner The Antibody Society
Have a peek into the dynamic panels, engaging roundtables, and hands-on workshops happening in Boston - right now!
Spatial Multi-Omics For Target-To-Disease Linkage In Inflammatory Diseases
MARINA BLECK, Principal Scientist, Boehringer Ingelheim
Marina discussed the use of multi omics for faster Faster Target-to- Disease Link (T2DL) with increased confidence and how they can leverage Spatial Biology to enhance the ability to derive insight from human disease tissues. Finally the Importance of FFPE Tissue Quality for Spatial Biology was discussed with the use of QC scoring to determine which FFPE tissue gives the best spatial transcriptomics results.
Spatial Biology As A Discovery Pathway
EMRE ARSLAN, Takeda
Emre Arslan from Takeda gave a talk about the use of Spatial Biology as a discovery pathway. First of all providing an update on the current landscape for spatial technologies then analysing how spatial technologies can be used in clinical trial design - such as the ability to identify previously unknown cell types, interactions and microenvironments and providing an ideal foundation for training better AI models.
JASMINE PLUMMER, Director, St Jude Children's Research Hosptial
Jasmine Plummer's day 2 keynote focused on Single cell into spatial and beyond. "The reason we are in this room is because it’s cutting edge" which is why the single cell and spatial field growing exponentially.
Future directions for the technology include Low throughput, clinical trials, other organisms, more tissue types, epigenomics
JUN WANG, Associate Professor, Multiplex Biotechnology Laboratory, Department of Biomedical Engineering, Stony Brook University
"Simpler but more powerful than flow and imaging cytometry"
MIST Technology provides100 times more information than flow cytometry and currently the highest multiplexity is up to 500 markers/ cell.
Panel Application Of Single Cell Omics In Clinical Monitoring
PRIYA CHOCKALINGAM, Vice President, Head of Clinical BioAnalytics & Translational Sciences, Beam Therapeutics
Priya's talk focused on Genome Editing Technologies for Gene & Cell Therapy and how cell & gene therapies require a specialized regulatory approach compared to other modalities. Appropriate assessments should therefore be put in place in both nonclinical and clinical stages to address safety concerns.
Various methods to assess off-target editing effects have evolved in the last decade. However, limitations remain in balancing accuracy vs sensitivity of these new techniques.
The direct assessment of off-target effects in vivo and in patients is particularly challenging.
Novel single-cell technologies enable quantitation/co-occurrence of on-/off-target editing through patient time-course of treatment
Comparative Insights In Single Cell RNA-seq & Advances In Large-Scale Multimodal Profiling
ZORA MODRUSAN, Senior Director NGS, Genentech
Zora focused on both key insights and future directions of single cell RNA-Seq. scRNA-seq technologies were evaluated and the differences in performance across various metrics such as sensitivity, throughput and cost were compared across different systems.
The Overloading And unpacKing (OAK) method provides a reliable solution for large-scale molecular profiling that incorporates multiple data modalities.
Moving forward they will continue to evaluate the latest scRNA-seq kits to understand differences and guide optimal performance. Zora would also like to enhance OAK's capabilities by integrating additional modalities and applying the platform to a wide range of biological systems.
Our 2026 Speakers
Become a driving force in accelerating the next generation of multi-omics-based treatments. NextGen Omics & Spatial Biology US offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, & academic experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, & collaborate with the community shaping the future of genomic medicine today.
Interested in Sponsoring NextGen Biomed?
Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.
Meet Our Esteemed Sponsors
Platinum Sponsors
Gold Sponsors
Silver Sponsors
Bronze Sponsors
Network & Programme Sponsors
Start-Ups
Our 2026 Partners & Sponsors
Diamond Sponsor
Platinum Sponsors
Gold Sponsors
Silver Sponsors
Bronze Sponsors
Network & Programme Sponsors
Interested in Sponsoring NextGen Omics, Spatial & Data US 2027?

Unlock the Latest News and Insights
Sign-up for our regular LifeScienceXchange newsletter to keep up to date with all things Precision Medicine, direct to your inbox.
